Stearylated cycloarginine nanosystems for intracellular delivery – simulations, formulation and proof of concept. Issue 114 (2nd December 2016)

• Record Type: Journal Article
• Authors: Dhawan, V.; Magarkar, A.; Joshi, G.; Makhija, D.; Jain, A.; Shah, J.; Reddy, B. V. V.; Krishnapriya, M.; Róg, T.; Bunker, A.; Jagtap, A.; Nagarsenker, M.
• Is Part Of: RSC advances. Volume 6:Issue 114(2016)
• Page Start: 113538
• Page End: 113550
• Publication Date: 2016-12-02
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c6ra16432c
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : Novel cationic agent liposomes performed better in silico translating in higher cellular uptake with reduced toxicity. Abstract : Cationization of nanocarriers has been sought after as a viable strategy to surmount cellular barriers that impede intracellular drug and gene delivery. A plethora of cationic compounds including both lipids and polymers have been designed and developed for efficient cellular penetration. The toxicity of these cationic agents, however, precludes their use in drug delivery. Conjugation with biomolecules like sugars and amino acids to produce novel cationic agents is being investigated to generate biocompatible molecules to achieve safe drug delivery. In this study, we propose to mitigate the toxicity of stearylamine, a cationic lipid, by tethering it to arginine, to yield a novel cationic ligand. Ligand loaded liposomes and nanoparticles were fabricated and evaluated for their surface charge and cellular uptake. Furthermore, molecular dynamics simulations were utilized as a tool to understand the accessibility of the novel ligand and stearylamine loaded liposomal systems. This paper presents the one pot synthesis of a novel stearylated arginine dipeptide and its incorporation in delivery systems along with its in vitro and in vivo toxicity evaluation.